• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝星状细胞衰老作为肝纤维化逆转的机制:维甲酸和 PPAR-γ信号通路的协同作用。

Senescence in hepatic stellate cells as a mechanism of liver fibrosis reversal: a putative synergy between retinoic acid and PPAR-gamma signalings.

机构信息

Gastroenterology Unit, IRCCS "Casa Sollievo della Sofferenza" Hospital, Viale dei Cappuccini, 1, San Giovanni Rotondo, FG, Italy.

Institute for Liver and Digestive Health, Royal Free Hospital, University College London (UCL), London, UK.

出版信息

Clin Exp Med. 2017 Aug;17(3):269-280. doi: 10.1007/s10238-016-0438-x. Epub 2016 Sep 21.

DOI:10.1007/s10238-016-0438-x
PMID:27655446
Abstract

Hepatic stellate cells (HSCs), also known as perisinusoidal cells, are pericytes found in the perisinusoidal space of the liver. HSCs are the major cell type involved in liver fibrosis, which is the formation of scar tissue in response to liver damage. When the liver is damaged, stellate cells can shift into an activated state, characterized by proliferation, contractility and chemotaxis. The activated HSCs secrete collagen scar tissue, which can lead to cirrhosis. Recent studies have shown that in vivo activation of HSCs by fibrogenic agents can eventually lead to senescence of these cells, which would contribute to reversal of fibrosis although it may also favor the insurgence of liver cancer. HSCs in their non-active form store huge amounts of retinoic acid derivatives in lipid droplets, which are progressively depleted upon cell activation in injured liver. Retinoic acid is a metabolite of vitamin A (retinol) that mediates the functions of vitamin A, generally required for growth and development. The precise function of retinoic acid and its alterations in HSCs has yet to be elucidated, and nonetheless in various cell types retinoic acid and its receptors (RAR and RXR) are known to act synergistically with peroxisome proliferator-activated receptor gamma (PPAR-gamma) signaling through the activity of transcriptional heterodimers. Here, we review the recent advancements in the understanding of how retinoic acid signaling modulates the fibrogenic potential of HSCs and proposes a synergistic combined action with PPAR-gamma in the reversal of liver fibrosis.

摘要

肝星状细胞(HSCs),也称为窦周细胞,是存在于肝脏窦周间隙的周细胞。HSCs 是肝纤维化过程中主要涉及的细胞类型,肝纤维化是肝脏损伤后形成疤痕组织的过程。当肝脏受损时,星状细胞可以转变为激活状态,其特征为增殖、收缩和趋化性。激活的 HSCs 分泌胶原疤痕组织,可导致肝硬化。最近的研究表明,纤维生成剂在体内激活 HSCs 最终可导致这些细胞衰老,尽管这可能有利于肝癌的发生,但也有助于逆转纤维化。处于非激活状态的 HSCs 在脂滴中储存大量视黄酸衍生物,这些衍生物在受损肝脏中细胞激活时逐渐耗尽。视黄酸是维生素 A(视黄醇)的代谢产物,可介导维生素 A 的功能,通常需要生长和发育。视黄酸及其在 HSCs 中的变化的确切功能尚未阐明,但在各种细胞类型中,视黄酸及其受体(RAR 和 RXR)与过氧化物酶体增殖物激活受体γ(PPAR-γ)信号协同作用,通过转录异二聚体的活性。在这里,我们综述了对视黄酸信号如何调节 HSCs 的纤维化潜能的理解的最新进展,并提出了与 PPAR-γ在逆转肝纤维化中的协同联合作用。

相似文献

1
Senescence in hepatic stellate cells as a mechanism of liver fibrosis reversal: a putative synergy between retinoic acid and PPAR-gamma signalings.肝星状细胞衰老作为肝纤维化逆转的机制:维甲酸和 PPAR-γ信号通路的协同作用。
Clin Exp Med. 2017 Aug;17(3):269-280. doi: 10.1007/s10238-016-0438-x. Epub 2016 Sep 21.
2
Wnt signaling in liver fibrosis: progress, challenges and potential directions.Wnt 信号通路在肝纤维化中的作用:进展、挑战与潜在方向。
Biochimie. 2013 Dec;95(12):2326-35. doi: 10.1016/j.biochi.2013.09.003. Epub 2013 Sep 13.
3
Epigenetic modifications in hepatic stellate cells contribute to liver fibrosis.肝星状细胞中的表观遗传修饰有助于肝纤维化。
Tohoku J Exp Med. 2013 Jan;229(1):35-43. doi: 10.1620/tjem.229.35.
4
The role of retinoic acid receptors in activated hepatic stellate cells.维甲酸受体在活化的肝星状细胞中的作用。
Med Hypotheses. 2013 Aug;81(2):222-4. doi: 10.1016/j.mehy.2013.04.045. Epub 2013 May 17.
5
GLIS2 Prevents Hepatic Fibrosis by Competitively Binding HDAC3 to Inhibit Hepatic Stellate Cell Activation.GLIS2 通过竞争性结合 HDAC3 抑制肝星状细胞激活来预防肝纤维化。
Cell Mol Gastroenterol Hepatol. 2023;15(2):355-372. doi: 10.1016/j.jcmgh.2022.10.015. Epub 2022 Oct 28.
6
Oral vitamin-A-coupled valsartan nanomedicine: High hepatic stellate cell receptors accessibility and prolonged enterohepatic residence.口服维生素 A 偶联缬沙坦纳米药物:高肝星状细胞受体易接近性和延长的肠肝循环滞留。
J Control Release. 2018 Aug 10;283:32-44. doi: 10.1016/j.jconrel.2018.05.021. Epub 2018 May 22.
7
GATA binding protein 2 mediates leptin inhibition of PPARγ1 expression in hepatic stellate cells and contributes to hepatic stellate cell activation.GATA结合蛋白2介导瘦素对肝星状细胞中PPARγ1表达的抑制作用,并促进肝星状细胞活化。
Biochim Biophys Acta. 2014 Dec;1842(12 Pt A):2367-77. doi: 10.1016/j.bbadis.2014.10.001. Epub 2014 Oct 8.
8
Retinoic acids and hepatic stellate cells in liver disease.视黄酸与肝星状细胞在肝脏疾病中的作用
J Gastroenterol Hepatol. 2012 Mar;27 Suppl 2:75-9. doi: 10.1111/j.1440-1746.2011.07007.x.
9
Vitamin C deficiency attenuates liver fibrosis by way of up-regulated peroxisome proliferator-activated receptor-gamma expression in senescence marker protein 30 knockout mice.维生素 C 缺乏通过上调衰老标记蛋白 30 敲除小鼠中过氧化物酶体增殖物激活受体-γ的表达来减轻肝纤维化。
Hepatology. 2010 May;51(5):1766-77. doi: 10.1002/hep.23499.
10
Amplified inhibition of stellate cell activation pathways by PPAR-γ, RAR and RXR agonists.PPAR-γ、RAR 和 RXR 激动剂对星状细胞激活途径的放大抑制作用。
PLoS One. 2013 Oct 1;8(10):e76541. doi: 10.1371/journal.pone.0076541. eCollection 2013.

引用本文的文献

1
9-cis-Retinoic Acid Improves Disease Modelling in iPSC-Derived Liver Organoids.9-顺式视黄酸改善诱导多能干细胞衍生的肝脏类器官中的疾病建模。
Cells. 2025 Jun 26;14(13):983. doi: 10.3390/cells14130983.
2
Drug delivery systems based on mesoporous silica nanoparticles for the management of hepatic diseases.基于介孔二氧化硅纳米颗粒的药物递送系统用于肝脏疾病的治疗
Acta Pharm Sin B. 2025 Feb;15(2):809-833. doi: 10.1016/j.apsb.2024.12.015. Epub 2024 Dec 20.
3
Extracellular vesicles targeting non-parenchymal cells: the therapeutical effect on liver fibrosis.

本文引用的文献

1
Activation of adenosine receptor A2A increases HSC proliferation and inhibits death and senescence by down-regulation of p53 and Rb.腺苷受体 A2A 的激活通过下调 p53 和 Rb 增加 HSC 的增殖并抑制其死亡和衰老。
Front Pharmacol. 2014 Apr 10;5:69. doi: 10.3389/fphar.2014.00069. eCollection 2014.
2
PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells.PNPLA3在人肝星状细胞中具有视黄醇棕榈酸酯脂肪酶活性。
Hum Mol Genet. 2014 Aug 1;23(15):4077-85. doi: 10.1093/hmg/ddu121. Epub 2014 Mar 25.
3
Amplified inhibition of stellate cell activation pathways by PPAR-γ, RAR and RXR agonists.
靶向非实质细胞的细胞外囊泡:对肝纤维化的治疗作用
eGastroenterology. 2024 Mar 19;2(1):e100040. doi: 10.1136/egastro-2023-100040. eCollection 2024 Jan.
4
Regression of hepatic fibrosis after pharmacological therapy for nonalcoholic steatohepatitis.非酒精性脂肪性肝炎药物治疗后肝纤维化的消退
World J Gastrointest Pharmacol Ther. 2024 Nov 5;15(6):97381. doi: 10.4292/wjgpt.v15.i6.97381.
5
Nano-laponite encapsulated coaxial fiber scaffold promotes endochondral osteogenesis.纳米锂皂石包裹的同轴纤维支架促进软骨内成骨。
Regen Biomater. 2024 Jul 4;11:rbae080. doi: 10.1093/rb/rbae080. eCollection 2024.
6
Retinoic acid modulation guides human-induced pluripotent stem cell differentiation towards left or right ventricle-like cardiomyocytes.维甲酸调控指导人诱导多能干细胞向左或右心室样心肌细胞分化。
Stem Cell Res Ther. 2024 Jun 21;15(1):184. doi: 10.1186/s13287-024-03741-0.
7
Can Nutraceuticals Support the Treatment of MASLD/MASH, and thus Affect the Process of Liver Fibrosis?营养保健品能否支持 MASLD/MASH 的治疗,从而影响肝纤维化的进程?
Int J Mol Sci. 2024 May 11;25(10):5238. doi: 10.3390/ijms25105238.
8
Targeting nuclear receptors for NASH/MASH: From bench to bedside.针对非酒精性脂肪性肝炎/代谢相关脂肪性肝炎的核受体:从 bench 到 bedside。 (注:bench可理解为实验室研究阶段,bedside可理解为临床应用阶段 ,这里直接保留英文未完全意译,因为准确翻译这两个词在该语境下较难找到完全对应的精准中文表述,直接保留英文更能体现原文专业语境)
Liver Res. 2024 Mar;8(1):34-45. doi: 10.1016/j.livres.2024.03.002.
9
Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead.肝纤维化中的表观遗传修饰:充满希望的治疗方向,但前路挑战重重。
Acta Pharm Sin B. 2024 Mar;14(3):1009-1029. doi: 10.1016/j.apsb.2023.10.023. Epub 2023 Nov 4.
10
Identification of functional genes in liver fibrosis based on bioinformatics analysis of a lncRNA-mediated ceRNA network.基于 lncRNA 介导的 ceRNA 网络的生物信息学分析鉴定肝纤维化中的功能基因。
BMC Med Genomics. 2024 Feb 20;17(1):56. doi: 10.1186/s12920-024-01813-x.
PPAR-γ、RAR 和 RXR 激动剂对星状细胞激活途径的放大抑制作用。
PLoS One. 2013 Oct 1;8(10):e76541. doi: 10.1371/journal.pone.0076541. eCollection 2013.
4
All-trans-retinoic acid ameliorates hepatic steatosis in mice by a novel transcriptional cascade.全反式视黄酸通过一种新的转录级联改善小鼠的肝脂肪变性。
Hepatology. 2014 May;59(5):1750-60. doi: 10.1002/hep.26699. Epub 2014 Mar 26.
5
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome.肥胖诱导的肠道微生物代谢物通过衰老分泌组促进肝癌。
Nature. 2013 Jul 4;499(7456):97-101. doi: 10.1038/nature12347. Epub 2013 Jun 26.
6
PPARγ signaling and metabolism: the good, the bad and the future.过氧化物酶体增殖物激活受体 γ 信号转导与代谢:好、坏与未来。
Nat Med. 2013 May;19(5):557-66. doi: 10.1038/nm.3159. Epub 2013 May 7.
7
Hepatic stellate cells in liver development, regeneration, and cancer.肝脏星状细胞在肝脏发育、再生和癌症中的作用。
J Clin Invest. 2013 May;123(5):1902-10. doi: 10.1172/JCI66369. Epub 2013 May 1.
8
Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts.基质细胞蛋白 CCN1 通过诱导肝星状细胞衰老促进肝纤维化的逆转。
Mol Cell Biol. 2013 May;33(10):2078-90. doi: 10.1128/MCB.00049-13. Epub 2013 Mar 18.
9
Fibroscan (transient elastography) for the measurement of liver fibrosis.用于测量肝纤维化的Fibroscan(瞬时弹性成像)。
Gastroenterol Hepatol (N Y). 2012 Sep;8(9):605-7.
10
Vitamin A and retinoid signaling: genomic and nongenomic effects.维生素 A 和类视黄醇信号转导:基因组和非基因组效应。
J Lipid Res. 2013 Jul;54(7):1761-75. doi: 10.1194/jlr.R030833. Epub 2013 Feb 24.